Profound Medical Corp. (NASDAQ: PROF) reported Q3 EPS of $0.26, $0.64 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $5.03 million versus the consensus estimate of $4.76 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.